Fotagliptin Benzoate
- Generic Name
- Fotagliptin Benzoate
The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus (T2DM)Renal Insuficiency
- Interventions
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT06883656
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, China
SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 408
- Registration Number
- NCT05801627
- Locations
- 🇨🇳
Peking University Hospital, Beijing, Beijing, China
SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2023-03-23
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 458
- Registration Number
- NCT05782192
- Locations
- 🇨🇳
1. Sun Yat-sen Memorial Hospital, Sun Yat-sen University,, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath